- Create motivation by rewarding, if able to produce and control waste according to the target - Improved data storage system and production reports for monitoring and controlling For the direction of sales
of last year by Baht 49.5 million or is equal to 48.4% which change in the same direction of revenue. The main reason was resulting from decrease in rental expense due to discount from COVID-19
million. In a better direction and collectible, amount of Baht 342.44 million which is along with the increment of revenue. Statement of financial Position Thousand Baht Consolidated as of Changes % 31 Dec
in Q1-2023. Total operating expenses in Q2-2023 have changed in the same direction and at a similar rate with the increase and decrease in revenue when compared to Q1- 2023 and Q2- 2022. However, the
in Q3–2024 have changed in line with the same direction, and the rate is also similar to the increase and decrease in revenue. When compared to the increase rate in the total operating expenses in Q3
, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the
1,921 million decreased by 7% compared to the previous year. It derived from: • Revenues from sales and services of medical device business for the year 2019 were Baht 1,798 million decreased by 3% in
(minute/s Postpaid Prepaid Blended VOU (GB/data s Postpaid Prepaid Blended Device Penetrat 4G‐handset Fixed Broadban FBB subscri FBB net add FBB ARPU ( 1H17 Snap For 1H17, AIS (excluding IC
% -2.4% Prepaid 113 92 86 -24% -6.5% Blended 138 118 112 -19% -5.1% VOU (GB/data sub/month) Postpaid 14.4 16.6 17.0 18% 2.3% Prepaid 10.3 11.1 13.8 34% 23% Blended 11.4 12.7 14.7 29% 16% Device Penetration
appropriate by Dhipaya Bodin as a joint venture. It will benefit potential shareholders in the medical device and distribution business. The current production and distribution line is Blood Line with a